Astroglial reactivity is a key modulator of Alzheimer's disease pathological progression

Wiesje Pelkmans; Juan Domingo Gispert

doi:10.1093/brain/awae354

Astroglial reactivity is a key modulator of Alzheimer's disease pathological progression

Brain. 2024 Dec 3;147(12):3973-3975. doi: 10.1093/brain/awae354.

Authors

Wiesje Pelkmans^{1

2}, Juan Domingo Gispert^{1

2

3

4

5}

Affiliations

¹ Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, 08005 Barcelona, Spain.
² Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain.
³ Universitat Pompeu Fabra, 08002 Barcelona, Spain.
⁴ Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain.
⁵ Centro Nacional de Investigaciones Cardiovasculares (CNIC), 28029 Madrid, Spain.

Abstract

This scientific commentary refers to ‘Association of glial fibrillary acid protein, Alzheimer's disease pathology and cognitive decline’ by Peretti et al. (https://doi.org/10.1093/brain/awae211).

Publication types

Editorial
Comment

Abstract

Publication types

Grants and funding